Risk Assessment Models and Event‐Free Survival in Pulmonary Arterial Hypertension

Documenti analoghi

• Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries
  di: Barbro Kjellström, et al.
  Pubblicazione: (2025)
• Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis
  di: Adam Engel Sällberg, et al.
  Pubblicazione: (2026)
• Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  di: Salaheldin Ahmed, et al.
  Pubblicazione: (2024)
• Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
  di: Marshaleen Henriques King, et al.
  Pubblicazione: (2025)
• Prognostic Role of Platelets in Pulmonary Arterial Hypertension
  di: Caio Julio Cesar dos Santos Fernandes, et al.
  Pubblicazione: (2025)